Cargando…
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
Breast cancer is the most common invasive tumor in women and the second leading cause of cancer-related death. Nanomedicine raises high expectations for millions of patients as it can provide better, more efficient, and affordable healthcare, and it has the potential to develop novel therapeutics fo...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504566/ https://www.ncbi.nlm.nih.gov/pubmed/32825618 http://dx.doi.org/10.3390/ijms21176018 |